Biomerica (BMRA) Preferred Shares (2020)

Biomerica (BMRA) reported Preferred Shares of $25714.0 for Q4 2020, little changed sequentially from $25714.0 in Q3 2020.

Biomerica (BMRA) Preferred Shares (2020) Analysis & Trends

Biomerica (BMRA) has 1 years of Preferred Shares data on file, last reported at $25714.0 in Q4 2020.

For the quarter ending Q4 2020, Preferred Shares changed N/A year-over-year to $25714.0; the trailing twelve-month figure through Nov 2020 stood at $25714.0 (changed N/A YoY), and the FY2020 full-year result was $25714.0, changed N/A from the prior year.
Preferred Shares steadied at $25714.0 in Q4 2020, from $25714.0 in the prior quarter.
In the past five years, Preferred Shares ranged from a high of $45714.0 in Q1 2020 to a low of $25714.0 in Q2 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn	-
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn	-
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn	-
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn	-
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn	-
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn	-
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn	-
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn	-
9	Smith & Nephew	25.80 Bn	25.22 Bn	-	-
10	Biomerica	4.85 Mn	3.51 Mn	-44,000.00	-

Download Data